NP / PA
Sisters Medical Clinic LLC
Sisters Medical Clinic LLC was paid $2.02M by Medicaid between Jan 2018 and Dec 2024, across 39 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 45% of everything it billed.
33Billing provider infoSISTERS MEDICAL CLINIC LLC
BASKIN, LA 71219
BASKIN, LA 71219
33aNPI1033646781assigned 05/12/2017
33bProvider typeFamily Nurse Practitioner
28Total paid$2.02M
24GClaims121,796
24DCodes billed39
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Louisiana
Rank by total paid#9 of 254
Median peer was paid$4K
This provider vs. median540×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,910 | $192K | |
| 2019 | 15,395 | $282K | |
| 2020 | 18,845 | $271K | |
| 2021 | 21,687 | $350K | |
| 2022 | 19,949 | $335K | |
| 2023 | 21,082 | $354K | |
| 2024incomplete | 14,928 | $237K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 45% | 22,451 | 15,190 | $904K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 20% | 8,146 | 5,667 | $407K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 7.7% | 1,883 | 1,369 | $156K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 5.3% | 2,854 | 1,991 | $107K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 4.8% | 12,207 | 8,514 | $96K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.7% | 3,769 | 2,675 | $74K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.6% | 1,137 | 987 | $73K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.0% | 14,644 | 8,527 | $40K |
| 69210 | 1.8% | 1,975 | 1,503 | $37K | |
| 86318 | 1.4% | 3,606 | 2,583 | $28K | |
| 81025 | <1% | 5,133 | 3,604 | $19K | |
| 81002 | <1% | 9,933 | 7,092 | $15K |
27 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 266 | $13K |
| 86308 | <1% | 3,553 | $12K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 330 | $9K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 8,175 | $9K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 720 | $5K |
| 97597 | <1% | 192 | $4K | |
| 99205 | Prolong outpt/office vis | <1% | 26 | $3K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 208 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 9,170 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 912 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 180 | $986.50 |
| 90756 | <1% | 91 | $548.07 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 50 | $520.30 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 109 | $504.03 |
| 92551 | <1% | 67 | $457.86 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 22 | $383.67 |
| 82962 | <1% | 215 | $343.44 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,808 | $267.92 |
| 99173 | <1% | 90 | $71.70 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 24 | $68.95 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 168 | $64.32 |
| 85018 | <1% | 67 | $55.42 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 6,240 | $53.08 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 22 | $4.26 |
| 83037 | 0% | 61 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 88 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 204 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJORDAN, TRACY (MANAGER)